Detalhe da pesquisa
1.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Lancet
; 397(10276): 797-804, 2021 02 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33581798
2.
Natural killer cell mobilization and egress following acute exercise in men with prostate cancer.
Exp Physiol
; 105(9): 1524-1539, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32715550
3.
Effect of androgen deprivation therapy on the contractile properties of type I and type II skeletal muscle fibres in men with non-metastatic prostate cancer.
Clin Exp Pharmacol Physiol
; 45(2): 146-154, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29044613
4.
Acute exercise induces distinct quantitative and phenotypical T cell profiles in men with prostate cancer.
Front Sports Act Living
; 5: 1173377, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37325799
5.
Prostate-specific membrane antigen from diagnostic to therapeutic target: radionuclide therapy comes of age in prostate cancer.
BJU Int
; 120(3): 310-312, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28380282
6.
Attenuation of Resting but Not Load-Mediated Protein Synthesis in Prostate Cancer Patients on Androgen Deprivation.
J Clin Endocrinol Metab
; 102(3): 1076-1083, 2017 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28359098
7.
Triple targeting of Auger emitters using octreotate conjugated to a DNA-binding ligand and a nuclear localizing signal.
Int J Radiat Biol
; 92(11): 707-715, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27010622
8.
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas.
Clin Cancer Res
; 15(13): 4484-92, 2009 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19549771